Abstract:Ketamine is primarily known as an effective NMDAR (N-methyl-D-aspartic acid receptor) blocker.As one of the intravenous anesthetics,ketamine has been widely used in clinical practice for more than 50 years,exhibiting several different outcomes besides the original anesthetic effects.Recent studies provide insights into the mechanisms of the following neuropharmacological effects of ketamine:(i) Anesthesia.The anesthetic effects of ketamine are mainly due to its ability to decrease the inter-cortical communications to generate dissociative anesthesia.Besides the well-known NMDAR,another target for ketamine to show anesthetic effects has been reported to be hyperpolarization-activated cyclic nucleotide-gated channels (HCN channels).(ii) Analgesia.Ketamine not only exhibits blockade on NMDAR in the central nervous system,but also reverses opioid tolerance when combined with morphine at a low dose.The affinity with sodium and potassium channels makes ketamine possible for analgesia at high doses.However,the clinical analgesic effect is currently controversial,and the algetic cases after the discontinuation of ketamine are probably caused by its metabolic product norketamine.(iii) Anti-depression.Ketamine is recently regarded as a rapid antidepressant drug for its contribution to neurogenesis through several molecular processes,such as the glutamate burst by activating presynaptic NMDAR and AMPAR (α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor),the synaptic protein synthesis and transportation by activating mTOR (mechanistic target of rapamycin),and the synaptic maturation by releasing BDNF (brain derived neurotrophic factor).At the circuit level,ketamine widely reconstructs circuits by dual regulation on NMDAR and AMPAR,and causes loss of phenotype of the PV GABAergic neurons (parvalbumin-positive interneurons).(iv) Side effects.Ketamine is strictly constrained for its psychiatric side effects resulted from the potent disruption on neural network stability,which shares similar neuro-circuit etiology with schizophrenia.Also,the potential ketamine-induced neuroapoptosis might generate risks for anesthesia during pregnancy and childhood,which is under deep investigation.Due to the potential risks of ketamine,more attention should be paid to the development of novel anesthetics keeping the anesthetic,analgesic and antidepressant effects of ketamine,however,without the potential psychiatric side effects.Thus,exceeding novel knowledge,makes ketamine a representative example for the complexity of anesthetics due to its global targets and dose-dependent properties,which provides a breakthrough point both for the mechanism researches for the working models of general anesthetics and for exploring the state of consciousness of human beings.

The Immune Regulatory Mechanism of Ketamine-Induced Psychiatric Disorders: A New Perspective on Drug-Induced Psychiatric Symptoms

Immunoregulation and Antidepressant Effect of Ketamine

Ketamine use disorder: preclinical, clinical, and neuroimaging evidence to support proposed mechanisms of actions

Uncovering the Underlying Mechanisms of Ketamine As a Novel Antidepressant

Alterations in Regional Homogeneity of Resting-State Brain Activity in Ketamine Addicts

Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism

Potential Mechanisms for Phencyclidine/ketamine-Induced Brain Structural Alterations and Behavioral Consequences

Ketamine a dissociative anesthetic: Neurobiology and biomolecular exploration in depression

Repurposing Ketamine in the Therapy of Depression and Depression-Related Disorders: Recent Advances and Future Potential

Ketamine in neuropsychiatric disorders: an update

An integrative view on the cell-type-specific mechanisms of ketamine's antidepressant actions

Ketamine abuse potential and use disorder

Advances in Research of Ketamine Addiction Mechanism

Research progress in the mechanisms of the clinical effects of ketamine

Psychoactive substances for the treatment of neuropsychiatric disorders

A Multiscale View of the Mechanisms Underlying Ketamine’s Antidepressant Effects: An Update on Neuronal Calcium Signaling

The Amino Acid Metabolism Pathway of Peripheral T Lymphocytes and Ketamine-Induced Schizophrenia-Like Phenotype

KETAMINE: Neural- and network-level changes

Biomarkers of ketamine's antidepressant effect: An umbrella review

Mechanisms of ketamine action as an antidepressant

Ketamine induces rapid antidepressant effects via the autophagy-NLRP3 inflammasome pathway